Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-08 · accession 0000899243-22-014551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-12 | 2022-04-08+ | VRTX | Lee Yuchun | Dir | S - Sale+OE | $279.43 | -4,000 | 3,027 | -57% | -$1.12M |
| DM | 2022-04-12 | 2022-04-08+ | VRTX | Lee Yuchun | Dir | M - OptEx | $81.54 | +4,000 | 3,875 | New | +$326.2K |
| DM | 2022-04-12 | 2022-04-08+ | VRTX | Lee Yuchun | Dir | M - OptEx | $0.00 | -4,000 | 10.0K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-08 | S | D | 418 | $276.62 | 3,457 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $276.62 (range $276.08 to $276.81). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-04-11 | S | D | 922 | $279.81 | 2,953 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $279.81 (range $279.29 to $280.18). |
| 3 | Common | Common Stock | 2022-04-08 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-08 | S | D | 452 | $280.37 | 1,875 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $280.37 (range $280.06 to $281.02). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2022-04-11 | S | D | 968 | $280.62 | 1,985 | D | — | — | (F8) Open market sales reported on this line occurred at a weighted average price of $280.62 (range $280.31 to $281.28). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2022-04-08 | S | D | 700 | $279.36 | 2,327 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $279.36 (range $278.86 to $279.74). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2022-04-11 | S | D | 110 | $281.58 | 1,875 | D | — | — | (F9) Open market sales reported on this line occurred at a weighted average price of $281.58 (range $281.55 to $281.58). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2022-04-11 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 9 | Common | Common Stock | 2022-04-08 | S | D | 430 | $277.29 | 3,027 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $277.29 (range $277.16 to $277.46). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-04-11 | M | D | 2,000 | $0.00 | 8,000 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F10) Fully vested. |
| 11 | Derivative | Stock Option (Right to Buy) | 2022-04-08 | M | D | 2,000 | $0.00 | 10,000 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F10) Fully vested. |